Previously, treatment with nicotine increased NSCLC cell proliferation while treatment with GABA, known to be a suppressive neurotransmitter, or the broad-spectrum β-AR antagonist, propranolol, had the opposite effect [23,30,31,47,58]. Here, ADRB2 is linked to non-small cell lung carcinoma.